Ann Rheum Dis
- VAN DER WOUDE D, Toes REM
Immune response to post-translationally modified proteins in rheumatoid
arthritis: what makes it special?
Ann Rheum Dis. 2024 Feb 20:ard-2023-224103. doi: 10.1136/ard-2023-224103.
- TANG Z, Shi H, Liu HL, Cheng X, et al
Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification
criteria'.
Ann Rheum Dis. 2024;83:e4.
- BARBHAIYA M, Zuily S, Hendry AM, Manneville F, et al
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome
classification criteria' by Tang et al.
Ann Rheum Dis. 2024;83:e5.
- DAMOISEAUX J, van Beers J
Correspondence on "ACR/EULAR antiphospholipid syndrome classification criteria".
Ann Rheum Dis. 2024;83:e6.
- ERKAN D, Barbhaiya M, Zuily S, Bertolaccini ML, et al
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome
classification criteria' by Miro-Mur et al.
Ann Rheum Dis. 2024;83:e3.
- BARBHAIYA M, Zuily S, Bertolaccini ML, Willis R, et al
Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome
classification criteria' by Damoiseaux and van Beers.
Ann Rheum Dis. 2024;83:e7.
- MIRO-MUR FA, Alijotas-Reig J, Anunciacion-Llunell A, Marques-Soares J, et al
Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification
criteria'.
Ann Rheum Dis. 2024;83:e2.
- PEZOT M, Nocturne G, Belkhir R, Henry J, et al
Obinutuzumab in patients with Sjogren's disease immunised against rituximab.
Ann Rheum Dis. 2024;83:407-408.
- DORNER T, Kaul M, Szanto A, Tseng JC, et al
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in
Sjogren's syndrome: results from a randomised, double-blind, placebo-controlled
phase 2 trial.
Ann Rheum Dis. 2024;83:360-371.
Arthritis Res Ther
- LI G, Fang Y, Xu N, Ding Y, et al
Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid
arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes.
Arthritis Res Ther. 2024;26:56.
Clin Exp Immunol
- IWAI T, Ohyama A, Osada A, Nishiyama T, et al
Role of inter-alpha-trypsin inhibitor heavy chain 4 and its citrullinated form in
experimental arthritis murine models.
Clin Exp Immunol. 2024;215:302-312.
Clin Exp Rheumatol
- KHULLAR A, Dhir V, Saikia B, Yadav AK, et al
Rheumatoid arthritis synovial fluid shows enrichment of T-cells producing GMCSF
which are polyfunctional for TNFalpha and IFNgamma.
Clin Exp Rheumatol. 2024 Feb 12. doi: 10.55563.
- CEN X, Chen Y, Liu H, Luo Y, et al
Methotrexate inhibits LPS-induced glycolysis in fibroblast-like synoviocytes
isolated from patients with rheumatoid arthritis.
Clin Exp Rheumatol. 2024 Feb 6. doi: 10.55563.
- FEDERICO JA, Syvaranta SA, Tuohinen SS, Holmstrom MM, et al
Myocardial T1 mapping by cardiac magnetic resonance imaging shows early
myocardial changes in treatment-naive patients with active rheumatoid arthritis
and positive autoantibodies.
Clin Exp Rheumatol. 2024 Feb 6. doi: 10.55563.
- ALP G, Cinakli H, Kurut Aysin I, Solmaz D, et al
Challenges and insights in managing difficult-to-treat rheumatoid arthritis:
real-world clinical perspectives.
Clin Exp Rheumatol. 2024 Jan 31. doi: 10.55563.
- GUO N, Li X, Movahedi M, Cesta A, et al
Biologics initiation in moderate versus severe rheumatoid arthritis: real-world
experience from a Canadian registry.
Clin Exp Rheumatol. 2024 Jan 31. doi: 10.55563.
Clin Orthop Relat Res
- WALTER N, Szymski D, Kurtz SM, Alt V, et al
What Are the Mortality, Infection, and Nonunion Rates After Periprosthetic
Femoral Fractures in the United States?
Clin Orthop Relat Res. 2023 Sep 5. doi: 10.1097/CORR.0000000000002825.
Clin Rheumatol
- PHAM C, Niu F, Hui RL, Le KN, et al
Patient perceptions on switching from reference product adalimumab to biosimilar
adalimumab-atto.
Clin Rheumatol. 2024;43:1269-1270.
- ESPINOSA-BAUTISTA F, Salazar-Sanchez MI, Brianza-Padilla M, Leon-Avila G, et al
Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept
study.
Clin Rheumatol. 2024;43:1253-1259.
- BAO X
Validation of new immune and inflammation-related diagnostic biomarkers for RA.
Clin Rheumatol. 2024;43:949-958.
- BOHMAN BR, Dowds HS, Blagogee TE, Ike RW, et al
Sjogren's disease activity associates with cardiovascular disease and monoclonal
gammopathy: a university cohort study of disease activity and comorbidities.
Clin Rheumatol. 2024;43:1093-1101.
- SUZUKI S, Kataoka Y, Otani T, Taniguchi Y, et al
Optimal time of starting tocilizumab in acute phase of adult-onset Still's
disease and comparison of its efficacy with that of methotrexate: a case series
and a review of the literature.
Clin Rheumatol. 2024;43:1245-1251.
- WANG B, Liu J, Zhao L
Association of congestive heart failure with mortality in individuals with
rheumatoid arthritis: a cohort study.
Clin Rheumatol. 2024 Feb 20. doi: 10.1007/s10067-024-06878.
- CHEN D, Zhang J
Commentary on the factors with liver fibrosis in rheumatoid arthritis patients
treated with methotrexate.
Clin Rheumatol. 2024 Feb 23. doi: 10.1007/s10067-024-06896.
Lancet
- VAN DER HELM-VAN MIL AHM
Abatacept in individuals with autoantibody-positive arthralgia at risk for
rheumatoid arthritis.
Lancet. 2024 Feb 14:S0140-6736(24)00055-2. doi: 10.1016/S0140-6736(24)00055.
- RECH J, Tascilar K, Hagen M, Kleyer A, et al
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals
at high risk (ARIAA): a randomised, international, multicentre, double-blind,
placebo-controlled trial.
Lancet. 2024 Feb 13:S0140-6736(23)02650-8. doi: 10.1016/S0140-6736(23)02650.
- COPE AP, Jasenecova M, Vasconcelos JC, Filer A, et al
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a
randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b
clinical trial.
Lancet. 2024 Feb 13:S0140-6736(23)02649-1. doi: 10.1016/S0140-6736(23)02649.
PLoS One
- BERGMANS B, Jessurun N, van Lint J, Murk JL, et al
Burden of non-serious infections during biological use for rheumatoid arthritis.
PLoS One. 2024;19:e0296821.
- DE ARAUJO BMM, de Miranda BM, Kowaltschuk TC, Goncalves FM, et al
Impact of chronic diseases on the periapical health of endodontically treated
teeth: A systematic review and meta-analysis.
PLoS One. 2024;19:e0297020.
Rheumatol Int
- SHARMA P, Brown S, Sokoya EM
Re-evaluation of dietary interventions in rheumatoid arthritis: can we improve
patient conversations around food choices?
Rheumatol Int. 2024 Feb 20. doi: 10.1007/s00296-024-05541.
Z Rheumatol
- SANDIKCI SC, Gultuna S, Ozisler C, Aydin FN, et al
The role of orexin in fatigue and sleep quality in patients with primary
Sjogren's syndrome.
Z Rheumatol. 2024;83.
- FIEHN C, Leipe J, Weseloh C, Bergner R, et al
Assessment of interactions and dosage recommendations of synthetic
DMARDs-Evidence-based and consensus-based recommendations based on a systematic
literature search.
Z Rheumatol. 2024;83.
- SEIFERT O, Baerwald C
Stimulation of the vagus nerve as a therapeutic principle.
Z Rheumatol. 2024;83.
- ALBRECHT K, Binder S, Minden K, Poddubnyy D, et al
Systematic review to estimate the prevalence of inflammatory rheumatic diseases
in Germany.
Z Rheumatol. 2024;83.
- ISIK AC, Kavas M, Tezcan ME
Metabolic syndrome may be more frequent in treatment-naive sarcoidosis patients.
Z Rheumatol. 2024;83.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016